As of February 10, 2023, the average one-year price target for Fulcrum Therapeutics is $23.01. The forecasts range from a low of $8.08 to a high of $36.75. The average price target represents an ...
As of February 1, 2023, the average one-year price target for Fulcrum Therapeutics is $22.33. The forecasts range from a low of $8.08 to a high of $36.75. The average price target represents an ...
TORONTO--(BUSINESS WIRE)--Fulcrum IT Partners ("Fulcrum") announces the successful acquisition of F3 Technology Partners (“F3”), marking the company's second U.S. acquisition and fourth global ...
After four months, Fulcrum Therapeutics finally has a permanent CEO: industry veteran Alex Sapir. The clinical-stage biopharmaceutical company named Sapir as its leader Monday, four months after CEO ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results